These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6293628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.
    Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin.
    Vignon F, Rochefort H.
    Endocrinology; 1976 Mar; 98(3):722-9. PubMed ID: 177271
    [Abstract] [Full Text] [Related]

  • 10. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S.
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V.
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [Abstract] [Full Text] [Related]

  • 13. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR, Willekes-Koolschijn N, Bevers MM, Van der Gugten AA, Misdorp W.
    Anticancer Res; 1986 Nov; 6(4):829-35. PubMed ID: 3019223
    [Abstract] [Full Text] [Related]

  • 14. Pathological review of breast lesions analyzed for estrogen receptor protein.
    Rosen PP, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Miké V, Fracchia A, Schwartz MK.
    Cancer Res; 1975 Nov; 35(11 Pt 1):3187-94. PubMed ID: 171066
    [Abstract] [Full Text] [Related]

  • 15. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
    Sutherland A, Forsyth A, Cong Y, Grant L, Juan TH, Lee JK, Klimowicz A, Petrillo SK, Hu J, Chan A, Boutillon F, Goffin V, Egan C, Tang PA, Cai L, Morris D, Magliocco A, Shemanko CS.
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
    [Abstract] [Full Text] [Related]

  • 16. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
    Canbay E, Degerli N, Gulluoglu BM, Kaya H, Sen M, Bardakci F.
    Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS.
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of ovariectomy on hormone receptors and growth of N-nitrosomethylurea-induced mammary tumors in the rat.
    Arafah BM, Gullino PM, Manni A, Pearson OH.
    Cancer Res; 1980 Dec; 40(12):4628-30. PubMed ID: 6254648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.